North America Retinal Vein Occlusion Treatment Market Size & Outlook
North America retinal vein occlusion treatment market, 2018-2030 (US$M)
Related Markets
North America retinal vein occlusion treatment market highlights
- The North America retinal vein occlusion treatment market generated a revenue of USD 1,032.5 million in 2022.
- The market is expected to grow at a CAGR of 6.1% from 2023 to 2030.
- In terms of segment, central retinal vein occlusion (crvo) was the largest revenue generating disease type in 2022.
- Branch Retinal Vein Occlusion (BRVO) is the most lucrative disease type segment registering the fastest growth during the forecast period.
- Country-wise, Canada is expected to register the highest CAGR from 2023 to 2030.
North America data book summary
| Market revenue in 2022 | USD 1,032.5 million |
| Market revenue in 2030 | USD 1,662.4 million |
| Growth rate | 6.1% (CAGR from 2022 to 2030) |
| Largest segment | Central retinal vein occlusion (crvo) |
| Fastest growing segment | Branch Retinal Vein Occlusion (BRVO) |
| Historical data covered | 2018 - 2021 |
| Base year for estimation | 2022 |
| Forecast period covered | 2023 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Central Retinal Vein Occlusion (CRVO), Branch Retinal Vein Occlusion (BRVO) |
| Key market players worldwide | AbbVie Inc, Roche Holding AG, Regeneron Pharmaceuticals Inc, Taiwan Liposome, Alcon Inc, CalciMedica Inc Ordinary Shares, Outlook Therapeutics Inc, Kodiak Sciences Inc, Chugai Pharmaceutical Co Ltd, Pfizer Inc |
Other key industry trends
- In terms of revenue, North America region accounted for 41.7% of the global retinal vein occlusion treatment market in 2022.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 1,084.3 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Retinal Vein Occlusion Treatment Market Scope
Retinal Vein Occlusion Treatment Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
North America retinal vein occlusion treatment market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to retinal vein occlusion treatment market will help companies and investors design strategic landscapes.
Central retinal vein occlusion (crvo) was the largest segment with a revenue share of 66.95% in 2022. Horizon Databook has segmented the North America retinal vein occlusion treatment market based on central retinal vein occlusion (crvo), branch retinal vein occlusion (brvo) covering the revenue growth of each sub-segment from 2018 to 2030.
Reasons to subscribe to North America retinal vein occlusion treatment market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of North America retinal vein occlusion treatment market databook
-
Our clientele includes a mix of retinal vein occlusion treatment market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the North America retinal vein occlusion treatment market , including forecasts for subscribers. This continent databook contains high-level insights into North America retinal vein occlusion treatment market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
North America retinal vein occlusion treatment market report size, by country, 2018-2030 (US$M)
North America Retinal Vein Occlusion Treatment Market Outlook Share, 2022 & 2030 (US$M)
Related industry reports
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
